Prevention of Future Deaths reports · 2023
Regulation 28 report to prevent future deaths, reference 2023-0518, written 11 Dec 2023. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.
| Date of report | 11 Dec 2023 |
|---|---|
| Reference | 2023-0518 |
| Deceased | Amarnih Lewis-Daniel |
| Coroner | Nadia Persaud |
| Coroner area | East London |
| Category | Other related deaths |
| Source | judiciary.uk record · original PDF |
| Responses published | 2 |
Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.
MISS N PERSAUD HIS MAJESTY'S AREA CORONER EAST LONDON East London Coroner's Court, Queens Road Walthamstow, E17 8QP REGULATION 28: REPORT TO PREVENT FUTURE DEATHS (1) REGULATION 28 REPORT TO PREVENT FUTURE DEATHS THIS REPORT IS BEING SENT TO: 1. NHS England 1 CORONER I am Nadia Persaud, Area Coroner for the coroner area of East London 2 CORONER'S LEGAL POWERS I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 and Regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. httQ:LLwww.legislation.gov.ukLukQgaL2009L25Lschedu1eL5LQaragraQhL7 httQ:LLwww.legislation.gov.ukLuksiL2013L1629LQartL7 Lmade 3 INVESTIGATION and INQUEST On 1 April 20211 commenced an investigation into the death of Amarnih Louis Lewis- Daniel, aged 24 years. The investigation concluded at the end of the inquest on the 30 November 2023. The conclusion of the inquest was a narrative conclusion delivered by a jury: Amarnih took the action that led to herfalling from floor window. The evidence does not fully disclose whether she intended the outcome to be fatal. 4 CIRCUMSTANCES OF THE DEATH Amarnih Lewis-Daniel suffered from traits of emotionally unstable personality disorder, mixed anxiety and depression, anger management difficulties and gender dysphoria. She was under assessment for autism spectrum disorder. Amarnih had been referred to the gender identity clinic in August 2018. The inquest heard evidence that Amarnih had suffered bullying and abuse, causing her a great deal of distress. She reported to professionals that she was keen to be accepted by and to receive treatment from the Gender Identity Clinic. Amarnih had sourced hormone medication The hormone medication was not supervised by any healthcare professional. In the months leading up to her death, Amarnih's mental state declined, and she came into contact with the police, criminal justice system and mental health professionals. On the 17 March 2021 she jumped fall. Amarnih was still awaiting care from the Gender Identity Clinic when she passed away. and sustained fatal injuries in the 5 CORONER'S CONCERNS During the course of the inquest the evidence revealed matters giving rise to concern. In my opinion there is a risk that future deaths could occur unless action is taken. In the circumstances it is my statutory duty to report to you. The MATTERS OF CONCERN are as follows: 1. The inquest heard that there are very long waiting lists for GID clinics. In September 2023, the average waiting time was in the region of 7 years. The expert instructed at the inquest identified that long waiting lists could intensify distress arising from gender dysphoria. 2. The inquest also heard that there is little local support available to patients who are waiting for assessment and treatment by Gender Identity Clinics. 3. There was a lack of clarity as to who is responsible for the wellbeing of the patient during the waiting period, for any distress caused by the gender dysphoria. There was a lack of consensus as to whether it would be the referrer or the GID clinic itself. 4. Local mental health services have very little specialist knowledge as to how best to support a person suffering from GID. 5. Those in attendance at the inquest were unclear about guidance available to GPs and other healthcare professionals to support them with the safe prescribing of bridging hormones, during the lengthy waiting period . The BMA' s guidance on the role of GPs in managing patients with gender incongruence (2022) and the Royal College of Psychiatrist's advice relating to bridging prescriptions was not known by the healthcare professionals in attendance at the inquest hearing. There is a concern that primary and secondary/tertiary services are not working optimally, to support those during the lengthy waiting periods. 6 ACTION SHOULD BE TAKEN In my opinion action should be taken to prevent future deaths and I believe you [AND/OR your organisation] have the power to take such action . 2 7 YOUR RESPONSE You are under a duty to respond to this report within 56 days of the date of this report, namely by 5 February 2024. I, the coroner, may extend the period. Your response must contain details of action taken or proposed to be taken, setting out the timetable for action. Otherwise, you must explain why no action is proposed. 8 COPIES and PUBLICATION I have sent a copy of my report to the Chief Coroner and to the following Interested persons: Family of Amarnih Lewis-Daniel, North-East London Foundation Trust and the Tavistock and Portman Clinic. I have also sent a copy to the local Director of Public Health who may find it useful or of interest and to the CQC. I am also under a duty to send a copy of your response to the Chief Coroner and all interested persons who in my opinion should receive it. I may also send a copy of your response to any other person who I believe may find it useful or of interest. The Chief Coroner may publish either or both in a complete or redacted or summary form. He may send a copy of this report to any person who he believes may find it useful or of interest. You may make representations to me, the coroner, at the time of your response, about the release or the publication of your response. 9 11 December 2023 3
2 responses published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.
Nadia Persaud
East London Coroner’s Court
Queens Road
Walthamstow
E17 8QP
Coroners@walthamforest.gov.uk
Dear Coroner,
National Medical Director
NHS England
Wellington House
133-155 Waterloo Road
London
SE1 8UG
england.coronersr28@nhs.net
7th February 2024
Re: Regulation 28 Report to Prevent Future Deaths – Amarnih Louis Lewis-
Daniel who died on 17 March 2021.
Thank you for your Report to Prevent Future Deaths (hereafter “Report”) dated 11
December 2023 concerning the death of Amarnih Louis Lewis-Daniel on 17 March
2021. In advance of responding to the specific concerns raised in your Report, I would
like to express my deep condolences to Amarnih’s family and loved ones. NHS
England are keen to assure the family and the coroner that the concerns raised about
Amarnih’s care have been listened to and reflected upon.
I apologise for the delay to responding to your Report, and for any anguish this delay
may have caused to Amarnih’s family or friends. I realise that responses to Coroner
Reports can form part of the important process of family and friends coming to terms
with what has happened to their loved ones and appreciate this will have been an
incredibly difficult time for them.
You will be aware that NHS England has previously provided a report on the
commissioning of specialised gender dysphoria services to you, to assist with your
investigation. For completeness, aspects of that report are repeated in the following
response. Given that Amarnih was aged 24 at the time of her death, our response
focuses on issues relating to the NHS pathway of care for adults with gender
dysphoria, and to national policy on mental health services for young people up to 25
years of age.
In your Report you raised five matters of concern. Some of these matters of concern
are better addressed by the Gender Dysphoria Clinic at the Tavistock and Portman
NHS Foundation Trust, the healthcare professionals directly involved in Amarnih’s
care at North East London NHS Foundation Trust and the Care Quality Commission
(CQC). We note that you have also addressed your Report to these organisations.
Background to NHS England’s role as Commissioner
NHS England is the direct commissioner of specialised services for individuals with a
diagnosis of gender dysphoria. Prior to 2019/20, seven specialist centres were
commissioned
in or near Newcastle, Leeds, Sheffield,
Northampton, Nottingham, London and Exeter. Each of the Gender Dysphoria Clinics
(GDCs) is operated by a Mental Health NHS Trust and is staffed by a multidisciplinary
team to include the wide range of clinical professionals needed to deliver highly
in England, based
individualised care and meet the presenting needs of the whole person (typically and
variously: clinical psychologists; specialist physicians; consultant psychiatrists;
consultant endocrinologists; clinical nurse specialists; voice and communication
therapists; counselling therapists).
The consultant-led services provided by the GDCs when adult patients are referred to
them are amongst those intended to commence within 18 weeks of referral. NHS
England has been unable to commission sufficient capacity to meet that expectation
because of the lack of specialist clinical staff (recruitment and retention) – against a
backdrop of significant increasing demand. Unfortunately, waiting times for a first
appointment at a GDC remain very high. Of patients who received their first
appointment in November 2023 they had on average been referred 382 weeks
previously.
You have raised the following matters of concern:
1. Very long waiting lists for Gender Dysphoria Clinics
NHS England has sought to address the serious imbalance between the demand for
gender dysphoria services and the shortage in trained clinicians who are available to
train and work in this field, which has led to long waiting times. In 2019/2020, NHS
England re-procured the provision of gender dysphoria services for adults. The
expectation was that that re-procurement would bring forward new entrants and enable
NHS England to increase the number of GDCs, and funding was identified by NHS
England for that purpose. That expectation was not met. In fact, no new providers
came forward from either the NHS or independent sector. All of the seven existing
GDCs submitted bids and award of renewal of contract was confirmed for all of them.
In the circumstances, NHS England sought to grow capacity in an alternative way. Five
pilot services were developed. The proposal was to build a new clinical workforce using
professionals who had tended not to specialise in gender identity healthcare previously,
based in primary care and local sexual health services, which presented the opportunity
to develop and expand clinical capacity to an extent not possible under the historical
delivery model. There were various eligibility criteria for accessing the different pilot
services (for example, being registered with a GP in the relevant geographical
catchment area) but all the pilot services only took patients from the waiting lists of the
established GDCs, in chronological order of waiting. Between April 2020 and August
2023 around 2,500 individuals were removed from a GDC waiting list to be seen by one
of the pilot services. They were located as follows:
a. The Trans Plus service, delivered in a sexual health setting at Chelsea and
Westminster Hospital NHS Foundation Trust in London (from April 2020)
b. The Indigo Service in Greater Manchester, based in primary care and
delivered by GTD Healthcare (from December 2020)
c. CMAGIC, a primary care service in Cheshire and Merseyside hosted by
Mersey Care NHS Foundation Trust (from March 2021)
d. The East of England Gender Service, managed by the Nottinghamshire
Healthcare NHS Foundation Trust in partnership with Cambridgeshire and
Peterborough NHS Foundation Trust (from June 2021)
e. A primary care service in Sussex hosted by Sussex Partnership NHS
Foundation Trust (from October 2023)
NHS England directly funded the pilot services on top of the funding provided to the
seven established GDCs.
In 2023 the pilot services at Chelsea and Westminster Hospital NHS Foundation Trust
(London) and GTD Healthcare (Greater Manchester) were moved to substantive seven-
year contracts with NHS England following positive evaluations. The GTD service is
now open to new referrals of patients who are registered with a GP in Greater
Manchester, and the London service is now taking increased numbers of patients from
the waiting list of its nearest GDC – the Tavistock and Portman NHS Foundation Trust.
NHS England is currently out to tender to award a substantive contract for the service
in Cheshire and Merseyside following positive evaluation of this service, and there is an
expectation that a similar process will be followed for the other two pilots when their
evaluations are complete in 2024 (East England) and 2026 (Sussex).
As mentioned above, to support the growth of clinical capacity NHS England also
established and funded the UK’s first accredited training programme in gender identity
healthcare which was launched in 2020 and delivered through the Royal College of
Physicians. The purpose of this investment is to encourage growth in the specialist
clinical workforce available to contribute to the assessment and care of those presenting
with gender incongruence and to treatment following a diagnosis of gender dysphoria.
NHS England also continues to support the expansion of services in the established
GDCs where this is possible. In 2021/22 NHS England invited all seven GDCs to put
forward a business case for funding for the expansion of clinical capacity or direct patient
support as part of a discretionary investment process. An additional investment of
£2.2m was set aside for this purpose. Although all this funding was deployed into the
GDCs by NHS England, some of the funding was directed by the providers to non-
clinical forms of support for patients on the waiting list due to the difficulties in attracting
clinical staff to work in the service itself. There is clinical opinion that telephone and
online support are a useful service for patients on the waiting list. We have also
commissioned support resources at Gender Dysphoria Clinics, to include:
• Screening at referral so that dedicated Named Professionals can work with
patients and GPs to address complex needs, and for signposting to local
services and local support groups in less complex cases.
• Gender Outreach Workers and Peer Support Workers who meet with patients
in local community settings.
• Advice and support lines delivered by third-sector support organisations.
• Pre-Assessment workshops with people on a waiting list, providing them with
information on assessment, intervention pathways and community-based
support.
The Gender Outreach Worker role (referred to above) is being formally evaluated
by a host Gender Dysphoria Clinic (Leeds and York Partnership NHS Foundation
Trust) so that learning can be shared across other NHS Gender Dysphoria Clinics
in 2024/25. The role has a number of potential positive benefits:
• Patients are signposted to local services for support in housing and
employment, as well as mental and physical health needs – helping to ensure
that such needs do not go un-met.
• Providing support at an earlier stage may mean reduced need for primary
and secondary care services further along the pathway including A&E and
crisis services.
• Patients are better informed and prepared for the process of assessment and
diagnosis once they are seen by the Gender Dysphoria Clinic
• Demands upon administrative and clinical staff are reduced, including the
need to manage distress, which frees up time for patients in the service.
• More tailored support can be offered to patients while on a waiting list, such
as those who are particularly vulnerable or who may have particular needs
(age; disability; ethnicity; health needs).
NHS England’s overall planned spend on all gender dysphoria services (adults and
children) in 2023/24 is £78.17m – up from £33.4m in 2018/19, representing an
overall increase in funding of 134% in five years. In 2024/25 NHS England will
refresh the service specifications for adult gender dysphoria services, which will
include consideration of how to identify and address inefficiencies that may reside
in the way in which GDCs manage and deliver their services and which may
contribute to long waiting times – and how to expand clinical capacity further taking
the learning from the pilot services. It is too early in the current year to provide
precise figures for the planned budget for gender dysphoria services in 2024/25 but
the figure given represents recurrent funding commitments and so should be
regarded as the opening baseline figure for planning assumptions.
2. Little local support for patients who are waiting for assessment at a GDC
Our response to concern number one above describes the support that GDCs may
provide to individuals on the waiting list alongside support from local health systems.
Commissioning responsibility for local services rests with Integrated Care Boards
(ICBs) rather than NHS England. The make-up of local services, and their approach
to service delivery, training and education, can differ according to each ICB’s
commissioning strategy.
Generally, NHS England expects local mental health services to have the necessary
skills, experience and competence to meet the needs of individuals who are on the
waiting list for gender dysphoria services and who have co-existing mental health
issues and / or personal, family or social complexities in their lives. Local services do
not need to be expert in the diagnosis of, and response to, gender dysphoria to meet
these needs, though the need to improve knowledge of the issues facing patients with
gender dysphoria amongst healthcare professionals in all healthcare settings is
recognised, and to that end there are various training and educational resources
available to local services and health professionals including:
• Training materials and courses delivered by NHS organisations; see for
example the courses available from the Nottingham Centre for Transgender
Health (Nottinghamshire Healthcare NHS Foundation Trust) which include
courses on “understanding trans youth” and “working with trans people at a
time of crisis”: https://ncth.nhs.uk/training
• General Medical Council advice for medical professionals on “Trans
Healthcare” including “the importance of providing good general medical
services to transgender and gender diverse people including supporting their
https://www.gmc-uk.org/professional-standards/ethical-
mental
hub/trans-healthcare
health”:
• Professional guidelines such as the British Psychological Society’s guidelines
for applied psychologists working with gender diverse individuals with mental
distress, but which may also be applied by health professionals working in
other disciplines including counselling, nursing, psychotherapy and social
work: https://explore.bps.org.uk/content/report-guideline/bpsrep.2019.rep129
• Various online courses for GPs through the Royal College of General
Practitioners including “Gender Variance” and “Mental Health and Suicide
Prevention”
• More specific to pathways of care for gender dysphoria, NHS England
commissioned the Royal College of Physicians to design and deliver the UK’s
first accredited post-graduate training course in gender identity healthcare; the
course began in 2020. Although aimed primarily at health professionals who
wish to specialise in gender identity healthcare, individual modules are also
suitable for other healthcare professionals who work in local settings and who
wish to improve the experience of individuals with gender dysphoria in using
generalist services intended for the whole population including mental health
services or primary care services: https://www.rcplondon.ac.uk/education-
practice/courses/gender-identity-healthcare-credentials-gih
In September 2023 NHS England published online training materials for health
and education professionals in how to support young people up to 18 years
with gender distress: https://www.minded.org.uk/catalogue/TileView
•
Local Mental Health Provision
From a policy perspective, the NHS Long Term Plan (LTP) contains a number of
commitments to expand access to community mental health support for those who
require it. This includes commitments for 345,000 more young people up to 25 years
to access to NHS funded support each year by 2023/24. This includes through brand
new Mental Health Support Teams in schools and colleges. We have seen significant
increases in the number of young people being supported. Over 732,000 children and
young people aged up to 18 years accessed NHS support in the year to October 2023.
This is an increase of 218,000 from the start of the LTP. However, the prevalence of
mental health need has also increased in recent years, with 20.3% of 8 to 16-year-
olds having a probable mental disorder in 2023, compared to 12.5% in 2017.
Increasing access remains a challenge despite the increases in young people being
supported.
The LTP also committed to delivering a comprehensive offer for 0 to 25 year olds that
reaches across mental health services for children and young people as well as adult
services. Integral to this is improving the care and support given to young adults aged
18-25, ending the use of rigid age-based thresholds which see young people
automatically discharged from children and young people’s mental health services
when they reach 18 years of age. Equally as important is improving the support given
to young adults within adult mental health services and NHS England is investing an
additional £1bn per year in transforming community mental health services so that
more people with severe mental health problems – including young adults – are able
to access support within their communities. The NHS has committed to ensuring that
by 2023/24 370,000 people (including young adults) will have access support through
these new models of care.
3. Lack of clarity on who is responsible for the wellbeing of the patient during
the waiting period
It is clear that no individual healthcare professional can be deemed to hold clinical
responsibility for a patient that they have never seen for the purpose of a clinical
consultation. Consequently, the individual healthcare professional that holds clinical
responsibility for a patient while they remain on the waiting list for a GDC will be the
patient’s GP, if the patient presents to the GP, or other local healthcare professional
who is involved in the provision of care to the individual. Our response above has
described some of the various training and support materials that are available to the
relevant health professionals.
We have also referenced the support that GDCs may provide to individuals on the
waiting list alongside support from local health systems, and, the expected role of local
services.
4. Local mental health services have very little specialist knowledge to support
a person with gender dysphoria
Our response above describes that local mental health services should be expected
to have the skills, experience and competence to meet the needs of individuals who
are on the waiting list for gender dysphoria services and who have co-existing mental
health issues and / or personal, family or social complexities in their lives. We have
also detailed some of the various training and support materials that are available to
local health professionals; and we have described the expansion of local mental health
provision through the NHS LTP.
5. Guidance on bridging prescriptions
Your investigation found that Amarnih had sourced hormone medication from the
internet. Although I understand distress may manifest as a response to the long
waiting times for a GDC, and although I have no direct knowledge of the circumstances
around Amarnih’s own care, the NHS strongly discourages the sourcing of unregulated
medications. The independent regulator of medical professionals in the United
Kingdom, the General Medical Council (GMC) has provided guidance to GPs about
patients who are awaiting to be seen by a GDC and who are self-medicating:
https://www.gmc-uk.org/professional-standards/ethical-hub/trans-
healthcare#Prescribing
In your accompanying letter to me you asked that I consider page 3 of the GMC
guidance that deals with prescribing, monitoring and follow-up after gender
reassignment treatment. This section of the guidance also provides advice to GPs
(and to other relevant medical professionals such as consultant endocrinologists) on
bridging prescriptions. The GMC explains that the information “is aimed at reassuring
doctors who wish to prescribe for their transgender and gender diverse patients that it
wouldn’t be against our guidance to do so, but it does not require doctors who do not
feel that prescribing would be of overall benefit to a patient to go down a particular
treatment route”. It goes on to advise that doctors:
“.. must work within their limits of their competence; should identify the likely cause of
the patient’s condition and which treatments are likely to meet their needs; should
reach agreement with the patient on the proposed treatment, explaining the likely
benefits, risks and impact, including serious and common side effects; what to do
in the event of a side effect or recurrence of the condition; how and when to take
the medicine and how to adjust the dose if necessary; how to use a medical device;
the likely duration of treatment; and any relevant arrangements for monitoring,
follow-up and review, including further consultation, blood tests or other
investigations, processes for adjusting the type or dose of medicine, and for issuing
repeat prescriptions”.
Your investigation found that this guidance was not widely known. It may be helpful to
know that it is referenced in various professional and regulatory guidelines, including
the Royal College of General Practitioners’ guidance on “Transgender Care” (2019)
and also in the Care Quality Commission’s guidance “Adult Trans Care Pathway: what
CQC Expects from GP Practices” (2022). We note that you have copied your report to
the CQC. GPs and other health professionals are also signposted to the GMC
guidance through the various webpages hosted by the GDCs, such as that of the
Tavistock and Portman NHS Foundation Trust, which also offers GPs advice through
a telephone “GP Hormone Advice Line”.
I would also like to provide further assurances on national NHS England work taking
place around the Reports to Prevent Future Deaths. All reports received are discussed
by the Regulation 28 Working Group, comprising Regional Medical Directors, and
other clinical and quality colleagues from across the regions. This ensures that key
learnings and insights around preventable deaths are shared across the NHS at both
a national and regional level and helps us pay close attention to any emerging trends
that may require further review and action.
Thank you for bringing these important patient safety issues to my attention and please
do not hesitate to contact me should you need any further information.
Yours sincerely,
National Medical Director
52 Walnut Tree Walk London SE11 6DN T 020 7780 7300 F 020 7780 7301 contact-us@together-uk.org www.together-uk.org Nadia Persaud His Majesty's Area Coroner for East London 124 Queens Road Walthamstow London E17 8QP 2nd January 2024 Dear Ms Persaud, Re: Inquest touching upon the death of Amarnih Louis Lewis-Daniel Please see below responses to the questions that you asked via letter on the 5th December 2023. 1. Detail of any information sharing protocols that Together has, with associated mental health trusts Together have separate ISAs in place with NELFT and also ELFT - attached. In addition, we have the Standard Operating Procedure for Liaison and Diversion (all providers) – attached. 2. Any training or guidance provided to Together staff in relation to the need to share risk information with a patient's NHS treating team. The practitioner was an agency member of staff with us through Liquid Personnel. It states on the contract we held with Liquid that is a qualified Social Worker with HCPC registration. When we recruit staff via agency for short term assignments ( was initially for a 2 month period, and he worked with us 5 months in total Dec 20 – May 21), we ensure staff come with an appropriate qualifications (such as Social Work or Psychology) which means they will have been subject to risk management, information sharing and safeguarding training as part of their professional training. It is Together’s practice that all staff, including agency staff are subject to an induction period led by their line manager in which all organisational policies in relation to risk management and information sharing, as well as any local protocols are discussed with them to confirm their understanding. We seek to work on a consent basis but staff are all inducted to the principles of defensible decision making, and that they can and must share information with care providers if there is a risk that needs to be shared to keep our service user or others safe. Staff will also shadow experienced Practitioners during this time. Learning also takes the form of regular feedback on work undertaken, highlighting best practice and learning, with Service Managers reviewing assessments and reports produced by the staff member regularly. Due to the short duration of agency assignments, Together’s training package relevant to the question posed here is not mandatory, however if a learning need is identified, we can offer staff online training in Data Protection and Security, Safeguarding Adults (Level 3), Safeguarding Children (Level 3), Recording Skills as well as classroom training on Formulation & Report Writing, Risk Management training and Trauma Informed Approach. Chief Executive: Registered office: 52 Walnut Tree Walk, London, SE11 6DN Registered charity no. 211091. Registered in England. A company limited by guarantee. Registration no. 463505. Permanent Together L&D Practitioners also have mandatory Professional Practice Meetings (clinical supervision from a qualified Forensic Psychologist), reflective practice and line management supervision to which they can take case discussions and discuss information sharing protocols. Depending on the Duration of their assignment, agency staff may be included to the PPM and RP sessions but will always have line management supervision in which cases are discussed. We also have an on call Manager available within the CJ team for any on the day queries staff may have in relation to cases. 3. Is Together part of the East London Care Records? This is a joint record platform hosted by Barts Health to improve the continuity of care across East London. If not part of the ELCR, is this something that could be considered? We do not have access to the ELCR, we have direct access to SystemOne which allows us to see the person’s GP summary care records but not their full medical history. We have been informed by ELFT that access to ELCR is part of the “One London Project”. We would be happy to raise this with ELFT and our L&D commissioner to see if it would be appropriate for Together staff to have direct access to ELCR and when we can piloted onto the ONE LONDON PROJECT. 4. If a Together practitioner wishes to seek collateral mental health history about a patient who is known to NELFT, how would they go about doing this? Are there any difficulties in accessing medical history from NELFT? The way Together L&D staff currently access information from the NELFT CMS (RiO) when we need to is via a named Team Administrator who is generally responsive to our requests for information on the same day. It is unknown whether was in possession of information that the Client had previously been known to NELFT in 2019, if this information was available to him, we would have expected him to liaise with NELFT in relation to current risk and need. With the case in question, the Practitioner ended their assignment with us in May 2021 and their line manager no longer works for Together. Based on the entry to the case management system we was compliant with the expectations of the role in the following were using at the time (ECase), ways: • • • • • did attempt to offer an L&D service to ALL-D both when referred by SERCO staff, and again after the Magistrate expressed their concern. subsequently recorded that ALL-D had declined an L&D assessment on both occasions. attempted to contact the AMHP service for advice on whether a MHAA needed to take place. did not request for the court to use Paragraph 5. It is not within the remit for an L&D Practitioner to do so, The case note indicated that the judiciary made this decision. shared information with the Probation Officer both by phone and email. Due to the time passed and that we do not have direct contact with at this time, it is not possible to verify if all of the below took place, however the following would be expected practice within the L&D role given the circumstances of this case: L&D Practitioner to escalate to a Together manager and the Practitioner or Together Manager to escalate to the AMHP Manager if they could not get through to the AMHP service to coordinate a MHAA on the day. L&D Practitioner to attempt to seek collateral information about this service user. As we were not on SystmOne at the time, the practice would have been for the Practitioner to contact the Clients GP if details were known, and to make enquires with the relevant NHS trust to see if she was known to any mental health teams. We know that at times defendants are seen in the court room before Practitioners have received responses to their enquiries as this is out of our control. Practitioners are expected to flag with the court (list caller and Judiciary) if they are awaiting/missing information relevant to risk and need at the time someone is called to court. The Practitioner would have been expected to liaise with the “B+D Mental Health Autistic Service” to see what was known about risk and need given the concerns about the Clients presentation at court, and if concerns were sufficient to breach confidentiality, to inform them of her upcoming court appearance at Romford CC in order that she could be offered appropriate support with the process. L&D Practitioner would be expected to record evidence of information sharing with the receiving prison about concerns relating to the Clients presentation, and the fact that a MHAA could not take place on the first day. If you have any further questions please do not hesitate to contact us for further information. Yours sincerely, Head of Quality Improvement
See every Prevention of Future Deaths report matching Nadia Persaud, and how often a new one appears.
What would an alert for this have sent me? Search the full text
Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.
These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.